Spinal Modulation Secures $45,002,251 New Financing Round

  • Feed Type
  • Date
    6/11/2013
  • Company Name
    Spinal Modulation
  • Mailing Address
    1135 O’Brien Dr. Menlo Park, CA 94025
  • Company Description
    The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
  • Website
    http://www.spinalmodulation.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,002,251
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.